XML 10 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Revenues        
Total Revenues $ 24 $ 5 $ 93 $ 80
Cost of revenues 2 0 5 0
Research and development expenses 1,780 1,434 4,166 4,435
Selling, general and administrative expenses 1,710 2,251 5,384 7,635
Total costs and expenses 3,492 3,685 9,555 12,070
Loss from Operations (3,468) (3,680) (9,462) (11,990)
Other Income        
Gain on investment in equity securities 0 0 0 12
Interest income 26 76 129 354
Interest expense (5) 0 (5) 0
Total Other Income 21 76 124 366
Income Tax Expense 0 0 (2) (2)
Net Loss (3,447) (3,604) (9,340) (11,626)
Other Comprehensive loss:        
Unrealized loss on available-for-sale debt securities (1) 0 0 (1)
Comprehensive Loss $ (3,448) $ (3,604) $ (9,340) $ (11,627)
Net loss per common share basic $ (0.19) $ (0.4) $ (0.55) $ (1.31)
Net loss per common share diluted $ (0.19) $ (0.4) $ (0.55) $ (1.31)
Weighted average shares used in computing net loss per common share basic 18,056,561 9,115,455 16,913,080 8,850,881
Weighted average shares used in computing net loss per common share diluted 18,056,561 9,115,455 16,913,080 8,850,881
Royalty Revenue [Member]        
Revenues        
Total Revenues $ 15 $ 5 $ 68 $ 80
Product Revenue [Member]        
Revenues        
Total Revenues $ 9 $ 0 $ 25 $ 0